Israel Real World Evidence Solutions Market Size & Outlook
Israel real world evidence solutions market, 2018-2030 (US$M)
Related Markets
Israel real world evidence solutions market highlights
- The Israel real world evidence solutions market generated a revenue of USD 7.1 million in 2023 and is expected to reach USD 15.1 million by 2030.
- The Israel market is expected to grow at a CAGR of 11.4% from 2024 to 2030.
- In terms of segment, services was the largest revenue generating component in 2023.
- Services is the most lucrative component segment registering the fastest growth during the forecast period.
Real world evidence solutions market data book summary
| Market revenue in 2023 | USD 7.1 million |
| Market revenue in 2030 | USD 15.1 million |
| Growth rate | 11.4% (CAGR from 2023 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Data Sets |
| Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Other key industry trends
- In terms of revenue, Israel accounted for 0.3% of the global real world evidence solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa real world evidence solutions market is projected to lead the regional market in terms of revenue in 2030.
- Israel is the fastest growing regional market in Middle East & Africa and is projected to reach USD 15.1 million by 2030.
Services was the largest segment with a revenue share of 57.75% in 2023. Horizon Databook has segmented the Israel real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
The RWE solution market in Israel is anticipated to show significant growth over the forecast period. Israel Ministry of Health (MoH), Pfizer, and BioN Tech recently revealed RWE, indicating the Pfizer BioN Tech COVID-19 vaccine, BNT162b2, resulted in decreased coronavirus incidence rates in fully vaccinated individuals in March 2021.
The real-world effectiveness data from Israel confirms the high efficacy demonstrated in phase III clinical trial and demonstrates significant impact of the vaccine in preventing severe disease & deaths due to COVID-19.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Real World Evidence Solutions Market Scope
Real World Evidence Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Israel real world evidence solutions market size, by component, 2018-2030 (US$M)
Israel Real World Evidence Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
